Home › Funds › Catalio Capital Management, LP › EW

Catalio Capital Management, LP position in EW

EDWARDS LIFESCIENCES CORP · Health Care

Catalio Capital Management, LP reported holding 124,778 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q2 2026 13F filing — a position valued at US$11.3M, representing 2.12% of its reported portfolio and ranking #18 among its reported holdings. Catalio Capital Management, LP has disclosed EW holdings in 6 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)124.78K sh
Reported value held$11.29M
Portfolio Weight2.12%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Catalio Capital Management, LP's EW position evolved

Catalio Capital Management, LP first disclosed a stake in EW in Q4 2024 at 333,144 shares (US$24.7M). The position peaked in Q1 2025 at 435,588 shares, worth US$31.6M. Across 6 filings, Catalio Capital Management, LP increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 124,778 shares valued at US$11.3M — a reduction of -19,829 shares quarter over quarter.. Notable position changes include a 31% increase in Q1 2025 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 333.14K $24.66M New
Q1 2025 435.59K $31.57M Add
Q2 2025 390.93K $30.57M Reduce
Q4 2025 187.05K $15.95M New
Q1 2026 144.61K $11.58M Reduce
Q2 2026 124.78K $11.29M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 34 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has Catalio Capital Management, LP held EW?

Catalio Capital Management, LP has disclosed EW holdings in 6 of the last 7 reported quarters, going back to Q4 2024.

What is Catalio Capital Management, LP's current position in EW?

As of Q2 2026, Catalio Capital Management, LP holds 124.78K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $11.29M, representing 2.12% of its reported portfolio and ranking #18.

Has Catalio Capital Management, LP been buying or selling EW?

In the latest 13F filing (Q2 2026), Catalio Capital Management, LP reduced its position in EW. The position peaked in Q1 2025 at 435.59K shares.

Which other funds hold EW?

Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.